Identification of novel aptamers targeting cathepsin B-overexpressing prostate cancer cells

Author:

Pereira Ana Cláudia123,Pina André F.45ORCID,Sousa Diana12,Ferreira Débora12,Santos-Pereira Cátia12,Rodrigues Joana L.12ORCID,Melo Luís D. R.12,Sales Goreti3ORCID,Sousa Sérgio F.45ORCID,Rodrigues Lígia R.12ORCID

Affiliation:

1. CEB – Centre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal

2. LABBELS – Associate Laboratory, Guimarães, Braga, Portugal

3. Biomark, Sensor Research, Superior Institute of Engineering of Porto, Rua Dr. António Bernardino de Almeida, 4249-015 Porto, Portugal

4. Associate Laboratory i4HB – Institute for Health and Bioeconomy, Faculty of Medicine, University of Porto, Alameda Professor Hernâni Monteiro, 4200-319 Porto, Portugal

5. UCIBIO – Applied Molecular Biosciences Unit, BioSIM – Department of Biomedicine, Faculty of Medicine, University of Porto, Alameda Professor Hernâni Monteiro, 4200-319 Porto, Portugal

Abstract

For the first time, an aptamer that specifically binds to cathepsin B (CatB)-overexpressing prostate cancer cells was identified by combining SELEX and computational tools.

Funder

Fundação para a Ciência e a Tecnologia

European Social Fund

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,Industrial and Manufacturing Engineering,Process Chemistry and Technology,Energy Engineering and Power Technology,Biomedical Engineering,Chemical Engineering (miscellaneous),Chemistry (miscellaneous)

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3